(Q28143552)

English

Auranofin versus placebo in rheumatoid arthritis

scientific article (publication date: 2000)

In more languages

edit

Statements

0 references

1 reference

Europe PubMed Central

title

Auranofin versus placebo in rheumatoid arthritis (English)

0 references

0 references

1 reference

ChEBI release 2020-05-28

1 reference

M E Suarez-Almazor

1

0 references

C H Spooner

series ordinal

2

0 references

E Belseck

series ordinal

3

0 references

B Shea

series ordinal

4

0 references

language of work or name

English

0 references

publication date

2000

0 references

published in

Cochrane Database of Systematic Reviews

0 references

issue

2

0 references

page(s)

CD002048

0 references

cites work

Auranofin therapy and quality of life in patients with rheumatoid arthritis. Results of a multicenter trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD002048

retrieved

21 January 2018

Auranofin is safe and superior to placebo in elderly-onset rheumatoid arthritis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD002048

retrieved

21 January 2018

Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD002048

retrieved

21 January 2018

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD002048

retrieved

21 January 2018

Identifying relevant studies for systematic reviews

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD002048

retrieved

21 January 2018

The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD002048

retrieved

21 January 2018

American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD002048

retrieved

21 January 2018

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD002048

retrieved

21 January 2018

Identifiers

DOI

10.1002/14651858.CD002048

0 references

PubMed publication ID

10796461

0 references

(Q28143552)

Auranofin versus placebo in rheumatoid arthritis

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)